
                She researched Type 2 diabetes and Alzheimerâ€™s Disease in a wet lab, and coupled this with research of socioeconomic factors that could minimize the risks of both diseases in marginalized populations. Ashlin is interested in increasing transparency and diversity within the clinical practice and biomedical research landscapes.